Envoy Medical Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Envoy Medical Inc's ROI in the second quarter of 2026?
Envoy Medical Inc recorded a cumulative net loss of $-23 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -406.67%.

Within the Healthcare sector 779 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3537 to 4383.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	155.38 %	155.09 %	-	298.13 %	-11.48 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	10	18	-4	-1	2
Return On Investment (TTM)	-406.67 %	-625.62 %	-	-	-1017.33 %
COCH's Overall Ranking	# 4383	# 3537	# 3742	# 3603	#
Seq. Investment Change TTM	55.78 %	-	-	-12.54 %	55.61 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-23	-23	-24	-22	-23

COCH Company Profile >> Back to COCH Roi Comparisons >> See Annual COCH Return On Investment

Return On Investment COCH's Ranking
Within:	No.
Industry	# 179
Sector	# 780
Overall	# 4383

Return On Investment Statistics
High	Average	Low
3.91 %	-349.73 %	-1835.15 %
(Sep 30 2022)		(Dec 31 2025)

News about Envoy Medical Inc Return on Investment ROI

Envoy Medical Secures Pivotal European Patent for Groundbreaking Modular Cochlear Implant System, Enhancing the Futur...

November 8, 2024

Envoy Medical Expands Intellectual Property Portfolio with New European Patent for Advanced Cochlear Implant System WHITE BEAR LAKE, Minnesota, Nov. 08, 2024 Envoy Medical, Inc. (NASDAQ: COCH), a pioneer in the development of fully implanted hearing systems, has announced a significant milestone in its quest to enhance auditory experiences for individuals with hearing loss. The European Patent Office has granted the company Patent No. 3858425, marking a pivotal step forward with the

Financial Statements
Envoy Medical Inc's II. Quarter Investments	$ 10 Millions	COCH's Balance sheet
Envoy Medical Inc's II. Quarter Income	$ -6 Millions	Quarterly COCH's Income Statement
COCH's Income by Division		See COCH's Income by Division

COCH Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	-11	4	1	423	424
Y / Y Investment Growth	-	167.74 %	-99.65 %	-0.22 %	-
Net Income in Millions	-24	-22	-30	19	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-561.3 %	-2002.81 %	4.54 %	-0.06 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
COCH's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for COCH's Competitors
Subscribers only: Roi for Envoy Medical Inc's Suppliers
Subscribers only: Return On Investment for COCH's Customers

Other Ratios
COCH's Roa	COCH's Inventory Turnover Ratio	COCH's Growth Rates	COCH's Dividend Statistics
	COCH's Profitability Ratios	COCH's Asset Turnover Ratio	COCH's Dividend Growth
COCH's Roe	COCH's Valuation Ratios	COCH's Financial Strength Ratios	COCH's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-08-12T19:54:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.